Cargando…

Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas

PTEN is a novel tumour-suppressor gene located on chromosomal band 10q23.3. This region displays frequent loss of heterozygosity (LOH) in a variety of human neoplasms including breast carcinomas. The detection of PTEN mutations in Cowden disease and in breast carcinoma cell lines suggests that PTEN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freihoff, D, Kempe, A, Beste, B, Wappenschmidt, B, Kreyer, E, Hayashi, Y, Meindl, A, Krebs, D, Wiestler, O D, Deimling, A von, Schmutzler, R K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362671/ https://www.ncbi.nlm.nih.gov/pubmed/10070865 http://dx.doi.org/10.1038/sj.bjc.6690121

Ejemplares similares

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
por: Hamilton, J A, et al.
Publicado: (2000)

Low Incidence of Germline and Somatic Alterations in the E-Cadherin Gene in Lobular Breast Carcinoma
por: Schmutzler, R. K., et al.
Publicado: (1999)

Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma
por: Kulke, M H, et al.
Publicado: (2001)

Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome
por: Burt, E C, et al.
Publicado: (1999)

Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
por: Gray, I. C., et al.
Publicado: (1998)

Characterizing Variants of Unknown Significance of the PTEN tumour suppressorHomolog DAF-18
por: Ermakova, Glafira, et al.
Publicado: (2022)

Effects of indomethacin on expression of PTEN tumour suppressor in human cancers
por: Abdulkareem, Imran Haruna, et al.
Publicado: (2013)

Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
por: Johnston, Sean B., et al.
Publicado: (2015)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
por: Moerland, E., et al.
Publicado: (1997)

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter–22q11.2
por: Hulsebos, T J M, et al.
Publicado: (1999)

Tumour suppressor PTEN activity is differentially inducible by myo‐inositol phosphates
por: Grzymajlo, Krzysztof, et al.
Publicado: (2023)

Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
por: Koopmann, J., et al.
Publicado: (1995)

Regulation of the tumor suppressor PTEN by SUMO
por: González-Santamaría, J, et al.
Publicado: (2012)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Mutation and deletion analysis of GFRα-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours
por: Gimm, O, et al.
Publicado: (1999)

Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer
por: Wappenschmidt, B, et al.
Publicado: (2005)

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
por: Jung, Y D, et al.
Publicado: (2001)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Somatic mutation of PTEN in bladder carcinoma
por: Aveyard, J S, et al.
Publicado: (1999)

Igf2 ligand dependency of Pten(+/−) developmental and tumour phenotypes in the mouse
por: Church, D N, et al.
Publicado: (2012)

Expression and association of IL-21, FBXL20 and tumour suppressor gene PTEN in laryngeal cancer
por: Yang, Qing, et al.
Publicado: (2019)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

PTEN: Tumor Suppressor and Metabolic Regulator
por: Chen, Chien-Yu, et al.
Publicado: (2018)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene
por: Liscia, D S, et al.
Publicado: (1999)

PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma
por: Molina, Jennifer R., et al.
Publicado: (2011)

Quantification of longitudinal tissue pO(2) gradients in window chamber tumours: impact on tumour hypoxia
por: Dewhirst, M W, et al.
Publicado: (1999)

Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas
por: Davies, M P A, et al.
Publicado: (1999)

Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours
por: Bradtmöller, Maren, et al.
Publicado: (2012)

Microsatellite instability in thyroid tumours and tumour-like lesions
por: Lazzereschi, D, et al.
Publicado: (1999)

PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
por: Luongo, Francesca, et al.
Publicado: (2019)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
por: Cao, Z, et al.
Publicado: (1999)

Major hepatic resection may suppress the growth of tumours remaining in the residual liver
por: Yokoyama, H, et al.
Publicado: (2000)

Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours
por: MacCallum, J, et al.
Publicado: (2000)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction
por: Pap, Thomas, et al.
Publicado: (2000)

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
por: Sun, Yizhe, et al.
Publicado: (2021)

Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies
por: Salles, Daniela C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fnhvnpk295dgbh8k7061g2qm0o